Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|July 17, 2020
Autophagy and Gastrointestinal DiseasesTao Wang, Kewei Liu, Liangzhi Wen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 8, 2022
Insights into the Effect of Catalytic Intratumoral Lactate Depletion on Metabolic Reprogramming and Immune Activation for Antitumoral ActivityJunlong Zhao, Zhimin Tian, Shoujie Zhao, et al.
Annals of Surgical Oncology|November 15, 2025
Identifying the Optimal Treatment for Patients with Hepatocellular Carcinoma and Clinically Significant Portal Hypertension: A Multicenter Propensity Score-Weighted AnalysisShoujie Zhao, Jinming Zhu, Yejing Zhu, et al.
Frontiers in Medicine|October 15, 2024
Development and validation of a prognostic score for TIPS placement in patients with viral hepatitis cirrhosis-related portal hypertension: a multi-center retrospective studyZenglong Que, Mingsong Wu, Shujie Lai, et al.
Surgical Endoscopy|May 16, 2025
Liver resection versus interventional treatments for hepatocellular carcinoma patients with hypohepatia: a multicenter studyShoujie Zhao, Yejing Zhu, Jinming Zhu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 12, 2023
A Ubiquitin-Dependent Switch on MEF2D Senses Pro-Metastatic Niche Signals to Facilitate Intrahepatic Metastasis of Liver CancerJunyu Xiang, Ni Zhang, Aibei Du, et al.
Cancer Letters|May 11, 2018
SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenanceTao Wang, Hong Wu, Sha Liu, et al.
International Journal of General Medicine|May 6, 2021
Prediction of Disease Progression of COVID-19 Based upon Machine LearningFumin Xu, Xiao Chen, Xinru Yin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 9, 2024
Stabilization of TGF-β Receptor 1 by a Receptor-Associated Adaptor Dictates Feedback Activation of the TGF-β Signaling Pathway to Maintain Liver Cancer Stemness and Drug ResistanceKewei Liu, Fanxuan Tian, Xu Chen, et al.
Nature Cell Biology|April 3, 2026
Aberrant amino acid-sensing promotes immunotherapy resistance via the inflammatory cytokine-ZBTB5-mTORC1 axisJunyu Xiang, Tao Wang, Shuoran Tian, et al.
Pageof 3